Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Crescita Therapeutics Inc T.CTX

Alternate Symbol(s):  CRRTF

Healthcare
Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. It also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER and Obagi Medical in Canada. The Licensing and Royalties segment engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. Manufacturing and Services segment engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and sales of product development services.


TSX:CTX - Post by User

Crescita Therapeutics Inc
<< Previous
 Bullboard Posts
User Avatar Image
(2172)
•••
Post by lscfaon Mar 15, 2024 12:37am
132 Views
Post# 35934218

Q4 on sedar

Q4 on sedar

Skincare biz growing. Looking for new customers for their contract manufacturing biz where the plant has a capacity of $25 mil/yr. 

 

 

Skincare

Licensing

Manufacturing

Total rev

ebitda

Dec 23

2,851

1,547

327

4,725

245

Sep 23

2,412

163

458

3,033

(988)

Jun 23

2,685

299

2,178

5,162

214

Mar 23

2,492

21

2,089

4,602

161

Dec 22

2,422

1,481

2,127

6,030

997

Sep 22

1,672

92

4,268

6,032

512

Jun 22

2,392

227

3,893

6,512

646

Mar 22

1,536

0

3,415

4,951

66

 

 

<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities